Velmanase Alfa-Tycv: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Velmanase Alfa-Tycv. Educational only — not medical advice.
Labeled uses
LAMZEDE is indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients.
Source: FDA labeling via NIH DailyMed (set 36d50a08…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.